Elosegi JA - Search Results

1

Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease.

Van den Bergh PY, Gérard JM, Elosegi JA, Manto MU, Kubisch C, Schoser BG. Van den Bergh PY, et al. Among authors: elosegi ja. J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1349-51. doi: 10.1136/jnnp.2003.028217. J Neurol Neurosurg Psychiatry. 2004. PMID: 15314133 Free PMC article.

2

A case of tardive tremor successfully treated with clozapine.

Delecluse F, Elosegi JA, Gérard JM. Delecluse F, et al. Among authors: elosegi ja. Mov Disord. 1998 Sep;13(5):846-7. doi: 10.1002/mds.870130517. Mov Disord. 1998. PMID: 9756158 No abstract available.

3

Levodopa for Parkinson's disease.

Gérard JM, Elosegi JA. Gérard JM, et al. Among authors: elosegi ja. N Engl J Med. 2009 Feb 26;360(9):936; author reply 936. N Engl J Med. 2009. PMID: 19256032 No abstract available.

4

Antiphospholipid syndrome-induced ischemic stroke following pembrolizumab: Case report and systematic review.

Tota V, Dagonnier M, Wery D, Binet L, Nagy N, Durieux V, Diaz M, Elosegi JA, Holbrechts S. Tota V, et al. Among authors: elosegi ja. Lung Cancer. 2021 Oct;160:59-65. doi: 10.1016/j.lungcan.2021.07.021. Epub 2021 Aug 3. Lung Cancer. 2021. PMID: 34411840 Review.

5

A case report of rigidity and recurrent lower limb myoclonus: progressive encephalomyelitis rigidity and myoclonus syndrome, a chameleon.

Degeneffe A, Dagonnier M, D'hondt A, Elosegi JA. Degeneffe A, et al. Among authors: elosegi ja. BMC Neurol. 2018 Oct 18;18(1):173. doi: 10.1186/s12883-018-1176-3. BMC Neurol. 2018. PMID: 30336789 Free PMC article.

6

Imaging of epilepsy following electrical injury.

Neugroschl C, Berrada S, Elosegi JA, Winant C. Neugroschl C, et al. Among authors: elosegi ja. JBR-BTR. 2013 Mar-Apr;96(2):81-3. doi: 10.5334/jbr-btr.215. JBR-BTR. 2013. PMID: 23847827

7

Minipolymyoclonus revealing Hirayama disease.

Oprea E, Elosegi JA. Oprea E, et al. Among authors: elosegi ja. Rev Neurol (Paris). 2024 Apr 10:S0035-3787(24)00482-X. doi: 10.1016/j.neurol.2024.02.391. Online ahead of print. Rev Neurol (Paris). 2024. PMID: 38604891 No abstract available.

8

Autoimmune GFAP-IgG astrocytopathy manifesting with acute cerebellitis and severe gastrointestinal symptoms.

Oprea E, Elosegi JA. Oprea E, et al. Among authors: elosegi ja. Rev Neurol (Paris). 2023 Dec;179(10):1147-1151. doi: 10.1016/j.neurol.2023.08.015. Epub 2023 Oct 17. Rev Neurol (Paris). 2023. PMID: 37858434 No abstract available.

9

Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer's Disease.

Colin IM, Szczepanski LW, Gérard AC, Elosegi JA. Colin IM, et al. Among authors: elosegi ja. touchREV Endocrinol. 2023 May;19(1):16-24. doi: 10.17925/EE.2023.19.1.16. Epub 2023 May 23. touchREV Endocrinol. 2023. PMID: 37313236 Free PMC article. Review.

10

Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: a study in a real life population.

Van Puyvelde K, Mets T; RODOS Study Group. Van Puyvelde K, et al. Geriatr Gerontol Int. 2011 Jul;11(3):256-61. doi: 10.1111/j.1447-0594.2010.00674.x. Epub 2011 Jan 4. Geriatr Gerontol Int. 2011. PMID: 21199235 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page